VLO
42
2
KLAC
59
2
NAVI
57
2
O
37
-3
SLB
50
4
PG
53
-2
PM
56
-8
PRGO
48
-2
COF
58
5
VRSK
38
-2
PNW
66
-3
CTSH
57
-5
CAH
54
-4
NTRS
49
2
ADI
59
2
AIG
53
2
ACN
43
-13
MMM
50
-2
JNPR
63
3
MET
51
4
VLO
42
2
KLAC
59
2
NAVI
57
2
O
37
-3
SLB
50
4
PG
53
-2
PM
56
-8
PRGO
48
-2
COF
58
5
VRSK
38
-2
PNW
66
-3
CTSH
57
-5
CAH
54
-4
NTRS
49
2
ADI
59
2
AIG
53
2
ACN
43
-13
MMM
50
-2
JNPR
63
3
MET
51
4
Financhill
Back

Kymera Therapeutics Stock Predictions

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Buy
60

KYMR
Kymera Therapeutics

Last Price:
46.42
Seasonality Move:
25.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $47.30. The Score for KYMR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
60
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • The current trend is moderately bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
50.19
52-Week Low:
9.60

Prediction Charts

Market Cap:
2.92B
Price in USD:
47.30
Volume:
327.62K
Beta:
2.20

Technical Analysis

SMA50:
44.55
SMA100:
39.17
SMA200:
36.24
52-Wk Change:
148.29%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 47.30 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 48.86 48.52 49.96 47.88
Aug-29 48.76 48.25 49.89 48.10
Aug-30 48.50 48.36 49.22 47.41
Sep-3 47.70 46.27 48.84 46.26
Sep-4 45.92 46.17 47.10 45.39
Sep-5 46.29 46.60 46.69 45.34
Sep-6 47.04 45.40 48.53 43.90
Sep-9 46.06 46.19 47.02 45.66
Sep-10 46.56 46.88 46.93 44.95
Sep-11 46.49 44.77 46.90 44.65
Sep-12 44.70 44.72 46.03 44.20
Sep-13 45.07 46.08 46.47 44.53
Sep-16 46.42 48.48 49.15 46.00
Sep-17 48.73 47.30 49.20 47.25

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.